Profiel
Jeff S.
Hartness currently works at Corganics LP, as Director from 2022, Bryn Pharma LLC, as Director from 2022, and Apogee Therapeutics, Inc., as Chief Commercial Officer from 2024.
Mr. Hartness also formerly worked at Bausch Health Cos., Inc., as Executive VP-Generics and Government Affairs.
Mr. Hartness received his undergraduate degree from Hanover College.
Actieve functies van Jeff Hartness
| Bedrijven | Functie | Begin |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 09-09-2024 |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Directeur/Bestuurslid | 23-02-2022 |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Directeur/Bestuurslid | 13-12-2022 |
Eerdere bekende functies van Jeff Hartness
| Bedrijven | Functie | Einde |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Algemeen Adviseur | - |
Opleiding van Jeff Hartness
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Hanover College
Hanover College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bausch Health Cos., Inc.
Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Corganics LP
Corganics LP Medical DistributorsDistribution Services Manufactures and distributes natural topical pain analgesic cream | Distribution Services |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
















